WELLINGTON MANAGEMENT GROUP LLP - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$2,008,000
+25.5%
13,280
+20.9%
0.00%
Q2 2022$1,600,000
-90.0%
10,984
-91.9%
0.00%
-100.0%
Q1 2022$16,041,000
+14.3%
135,284
+32.8%
0.00%
+50.0%
Q4 2021$14,036,000
+0.0%
101,847
+0.8%
0.00%0.0%
Q3 2021$14,034,000
-47.8%
101,032
-63.5%
0.00%
-50.0%
Q2 2021$26,876,000
-78.3%
276,842
-84.7%
0.00%
-81.8%
Q1 2021$124,079,000
-8.7%
1,815,354
+14.4%
0.02%
-12.0%
Q4 2020$135,958,000
-10.6%
1,586,252
-32.2%
0.02%
-19.4%
Q3 2020$152,163,000
-0.1%
2,340,609
+12.3%
0.03%
-8.8%
Q2 2020$152,315,000
+43.5%
2,083,381
-33.2%
0.03%
+21.4%
Q1 2020$106,120,000
+26.6%
3,118,373
+102.5%
0.03%
+55.6%
Q4 2019$83,821,000
+44.3%
1,539,665
+10.6%
0.02%
+38.5%
Q3 2019$58,096,000
+36.5%
1,392,520
+43.3%
0.01%
+44.4%
Q2 2019$42,550,000
-40.3%
971,721
-29.8%
0.01%
-43.8%
Q1 2019$71,274,000
+22.3%
1,384,766
-12.2%
0.02%
+6.7%
Q4 2018$58,295,000
+29.7%
1,576,424
+31.7%
0.02%
+66.7%
Q3 2018$44,949,000
+4.9%
1,197,050
+10.5%
0.01%
-10.0%
Q2 2018$42,830,000
+53.8%
1,083,723
+0.2%
0.01%
+66.7%
Q1 2018$27,848,000
+99.1%
1,081,064
+108.5%
0.01%
+100.0%
Q4 2017$13,986,000
-54.7%
518,431
-37.2%
0.00%
-57.1%
Q3 2017$30,854,000
+246.5%
825,445
+131.8%
0.01%
+250.0%
Q2 2017$8,904,000356,1070.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 450,422$6,251,85714.11%
Liontrust Investment Partners LLP 134,659$7,478,9610.13%
Birchview Capital, LP 7,365$1020.07%
FNY Investment Advisers, LLC 250$30.00%
FNY Investment Advisers, LLC 18$00.00%
FNY Investment Advisers, LLC 56$00.00%
McElhenny Sheffield Capital Management, LLC 31$4300.00%
Blue Trust, Inc. 65$100.00%
IFP Advisors, Inc 1$10.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders